When

Tuesday, March 28, 2017

12:00 PM - 1:15 PM

WheRE

San Diego, CA

San Diego Convention Center
Ballroom 6 CD
San Diego, CA

faculty

Michael E. Wechsler, MD, MMSc (Virtual Professor)
Professor, Department of Medicine
Co-Director, The Cohen Family Asthma Institute
Division of Pulmonary, Critical Care, and Sleep Medicine
Director, Asthma Program
National Jewish Health
Denver, Colorado

Steven F. Weinstein, MD
Director
Allergy and Asthma Specialists Medical Group and Research Center
Huntington Beach, California

Barbara P. Yawn, MD, MSc, FAAFP
Adjunct Professor, Department of Family and Community Health
University of Minnesota
Minneapolis, Minnesota

This activity is jointly provided by Global Education Group and Integritas Communications.

This activity is supported by an educational grant from AstraZeneca.

This event is not a part of the official Internal Medicine Meeting 2017 Education Program.

Target Audience

The educational design of this activity addresses the needs of internal medicine physicians and other primary care providers who treat patients with severe asthma.

Statement of Need/Program Overview

Between 5% and 15% of the more than 25 million Americans with asthma have a severe form of the disease.1 Even with multimodal therapy, many patients with severe asthma continue to suffer from uncontrolled symptoms, increased mortality risks, significant health-related consequences from disease exacerbations, and markedly negative effects on daily functioning and quality of life.1,2 Evolving insights into the pathophysiologic underpinnings of various asthma phenotypes have paved the way for new targeted therapies that are changing best-practice recommendations for the management of severe disease.3 This Interactive Exchange™ program will open with a brief 3D animated video highlighting mechanistic insights into asthma development and progression. Faculty experts with experience in clinical immunology, pulmonology, and primary care will discuss practical strategies to identify patients with severe asthma, review the clinical profiles of current and emerging biologic treatment options, and provide recommendations for coordinating multidisciplinary care.

References

  1. Levy ML. The national review of asthma deaths: what did we learn and what needs to change? Breathe (Sheff). 2015;11(1):14-24.
  2. Chung KF, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343-373.
  3. Walsh GM. Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma—an update. Expert Rev Clin Immunol. 2017;13(2):143-149.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Diagnose severe asthma using criteria from evidence-based clinical practice guidelines and ongoing evaluations of symptoms and treatment responses
  • Discuss the mechanisms of action and clinical profiles of cytokine-targeting biologic medications in the treatment of severe asthma
  • Coordinate with specialists to tailor therapy for patients with severe asthma to address the degree of disease control, exacerbation risks, and history of asthma-related hospitalizations
  • Educate patients with severe asthma and their caregivers about treatment options, asthma action plans, and adherence

Program Agenda

12:00 PM – 12:15 PM: Registration and Lunch

12:15 PM – 12:20 PM: Introduction and Preassessment

12:20 PM – 12:25 PM: Disease Primer: Severe Asthma Pathophysiology

12:25 PM – 1:00 PM: Meet the Professors: Patient Identification, Evaluation, and Treatment

1:00 PM –1:05 PM: Postassessment

1:05 PM –1:15 PM: Question and Answer Session

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.

This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Mike Remsen prior to the live event at mremsen@integritasgrp.com.

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Register Now

attend event